Download FREE Report Sample
Download Free sampleBudesonide Inhalation Suspension should be administered via jet nebulizer connected to an air compressor with an adequate air flow, equipped with a mouthpiece or suitable face mask. Ultrasonic nebulizers are not suitable for the adequate administration of Budesonide Inhalation Suspension and, therefore, are not recommended.
Injectable Suspension Budesonide Market contains market size and forecasts of Injectable Suspension Budesonide in global, including the following market information:
Global Injectable Suspension Budesonide Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Injectable Suspension Budesonide Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Injectable Suspension Budesonide companies in 2021 (%)
The global Injectable Suspension Budesonide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
0.5mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Injectable Suspension Budesonide include AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation and Cipla, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Injectable Suspension Budesonide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Suspension Budesonide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Injectable Suspension Budesonide Market Segment Percentages, by Type, 2021 (%)
0.5mg
1mg
Global Injectable Suspension Budesonide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Injectable Suspension Budesonide Market Segment Percentages, by Application, 2021 (%)
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Other
Global Injectable Suspension Budesonide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Injectable Suspension Budesonide Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injectable Suspension Budesonide revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Injectable Suspension Budesonide revenues share in global market, 2021 (%)
Key companies Injectable Suspension Budesonide sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Injectable Suspension Budesonide sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
